Foramen magnum metastatic malignant melanoma

Neurology India

Volumn 51, Issue 1, 2003, Pages 79-80

  Pai, S Balaji ^a   Krishna, K N ^a  

^a M S RAMAIAH MEDICAL COLLEGE   (India)

Author keywords

Brain metastases; Craniospinal tumor; Foramen magnum; Malignant melanoma

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; ATAXIA; BRAIN METASTASIS; BRAIN TOMOGRAPHY; BRAIN TUMOR; CANCER RADIOTHERAPY; CASE REPORT; CEREBELLUM VERMIS; CLINICAL FEATURE; CRANIAL NERVE PARALYSIS; CRANIECTOMY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FOLLOW UP; FORAMEN MAGNUM; HISTOPATHOLOGY; HUMAN; HYDROCEPHALUS; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; LAMINECTOMY; MALE; MELANOMA; MENINGIOMA; NEURILEMOMA; PAPILLEDEMA; POSTOPERATIVE PERIOD; SKULL CANCER; SYMPTOMATOLOGY; VERTEBRAL CANAL;

ADULT; BRAIN NEOPLASMS; FORAMEN MAGNUM; HUMANS; MALE; MELANOMA; SKIN NEOPLASMS; SPINAL NEOPLASMS;

EID: 0042805130     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Ramamurthi B. Metastatic deposits. In: Ramamurthi B, Tandon PN, editors. Textbook of Neurosurgery. New Delhi: B. I. Churchill Livingstone Pvt. Ltd; 1996. Vol 2. pp. 1118-23.
2. Oredsson S, Ingvar C, Stromblad LG, Jonsson PE. Palliative surgery for brain metastases of malignant melanoma. Eur J Surg Oncol 1990;16:451-6.
3. Reider-Groswasser I, Merimsky O, Karminsky N, Chaitchik S. Computed tomographic features of cerebral spread of malignant melanoma. Am J Clin Oncol 1996;19:49-53.
4. Araujo JF, Sperlescu A, Melacci EB, Balbo RJ. Brain metastasis of malignant melanoma. Analysis of 13 cases. Arq Neuropsiquiatr 1997;55:292-7.
5. Munoz JE, Vinolas N, Castro J, Graus F, Conde C, Castel T, et al. Cerebral metastasis of melanoma: Study of 48 patients. Med Clin (Barc) 1993;101:684-7.
6. Dewulf P, Demaerel P, Wilms G, Delanote G, Defloor E, Casselman J, et al. Cerebral metastatic malignant melanoma: CT and MRI findings with pathological correlation. J Belge Radiol 1993;76:318-9.
7. Weller M, Stevens A, Sommer N, Wietholter H. Intrathecal IgM response in disseminated cerebrospinal metastasis from malignant melanoma. J Neurooncol 1993;16:55-9.
8. Boaziz C, Breau JL, Morere JF, Israel L. Brain metastases of malignant melanomas. Bull Cancer (Paris) 1991;78:347-53.
9. Falkson CI, Falkson G, Falkson HC. Phase II trial of fotemustine in patients with metastatic malignant melanoma. Invest New Drugs 1994;12:251-4.
10. Chang J, Atkinson H, Hern R, Lorentzos A, Gore ME. A phase II study of the sequential administration of dacarbazine and fotemustine in the treatment of cerebral metastases from malignant melanoma. Eur J Cancer 1994;30A:2093-5.
11. Jacquillat C, Khayat D, Banzet P, Weil M, Fumoleau P, Avril MF, et al. Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases. Cancer 1990;66:1873-8.
12. Richard MA, Grob JJ, Zarrour H, Basseres N, Bizzari JP, Gerard B, et al. Combined treatment with dacarbazine, cisplatin, fotemustine and tamoxifen in metastatic malignant melanoma. Melanoma Res 1998;8:170-4.
13. Davey P, O'Brien P. Disposition of cerebral metastases from malignant melanoma: Implications for radiosurgery. Neurosurgery 1991;28:8-14.
14. Banayan A, Vital C. Long term survival after metastatic cerebral melanoma. Neurochirurgie 1998;44:275-7.